396 related articles for article (PubMed ID: 28617871)
21. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.
Iempridee T; Das S; Xu I; Mertz JE
J Virol; 2011 Aug; 85(15):7836-48. PubMed ID: 21593157
[TBL] [Abstract][Full Text] [Related]
23. The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites.
Kalla M; Göbel C; Hammerschmidt W
J Virol; 2012 Jan; 86(1):447-58. PubMed ID: 22031942
[TBL] [Abstract][Full Text] [Related]
24. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
[TBL] [Abstract][Full Text] [Related]
25. BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.
Woellmer A; Arteaga-Salas JM; Hammerschmidt W
PLoS Pathog; 2012 Sep; 8(9):e1002902. PubMed ID: 22969425
[TBL] [Abstract][Full Text] [Related]
26. A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.
Bristol JA; Djavadian R; Albright ER; Coleman CB; Ohashi M; Hayes M; Romero-Masters JC; Barlow EA; Farrell PJ; Rochford R; Kalejta RF; Johannsen EC; Kenney SC
PLoS Pathog; 2018 Jul; 14(7):e1007179. PubMed ID: 30052684
[TBL] [Abstract][Full Text] [Related]
27. Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.
Robinson AR; Kwek SS; Hagemeier SR; Wille CK; Kenney SC
J Virol; 2011 Sep; 85(17):8940-53. PubMed ID: 21697476
[TBL] [Abstract][Full Text] [Related]
28. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.
Ellis-Connell AL; Iempridee T; Xu I; Mertz JE
J Virol; 2010 Oct; 84(19):10329-43. PubMed ID: 20668090
[TBL] [Abstract][Full Text] [Related]
29. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.
Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X
J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723
[TBL] [Abstract][Full Text] [Related]
30. BZLF1 transcript variants in Epstein-Barr virus-positive epithelial cell lines.
Needham J; Adamson AL
Virus Genes; 2019 Dec; 55(6):779-785. PubMed ID: 31552622
[TBL] [Abstract][Full Text] [Related]
31. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
[TBL] [Abstract][Full Text] [Related]
32. Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells.
Sung WW; Chu YC; Chen PR; Liao MH; Lee JW
Cancer Lett; 2016 Nov; 382(1):21-31. PubMed ID: 27567526
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
[TBL] [Abstract][Full Text] [Related]
34. Radiation-induced Epstein-Barr virus reactivation in gastric cancer cells with latent EBV infection.
Nandakumar A; Uwatoko F; Yamamoto M; Tomita K; Majima HJ; Akiba S; Koriyama C
Tumour Biol; 2017 Jul; 39(7):1010428317717718. PubMed ID: 28675108
[TBL] [Abstract][Full Text] [Related]
35. Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus.
Gorres KL; Daigle D; Mohanram S; McInerney GE; Lyons DE; Miller G
mBio; 2016 Mar; 7(2):e00113. PubMed ID: 26933051
[TBL] [Abstract][Full Text] [Related]
36. Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1.
Hulse M; Caruso LB; Madzo J; Tan Y; Johnson S; Tempera I
PLoS Pathog; 2018 Nov; 14(11):e1007394. PubMed ID: 30395643
[TBL] [Abstract][Full Text] [Related]
37. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
[TBL] [Abstract][Full Text] [Related]
38. Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells.
Nawandar DM; Wang A; Makielski K; Lee D; Ma S; Barlow E; Reusch J; Jiang R; Wille CK; Greenspan D; Greenspan JS; Mertz JE; Hutt-Fletcher L; Johannsen EC; Lambert PF; Kenney SC
PLoS Pathog; 2015 Oct; 11(10):e1005195. PubMed ID: 26431332
[TBL] [Abstract][Full Text] [Related]
39. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch.
Wille CK; Nawandar DM; Henning AN; Ma S; Oetting KM; Lee D; Lambert P; Johannsen EC; Kenney SC
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7257-65. PubMed ID: 26663912
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q
J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
